Physician profile
Raul Benavides
NPI 1780880849
$10,481.04
in general payments reported to CMS, 2019-2025
10 companies · $4,450 in 2025
The $4,450 reported for 2025 was more than what 82% of Clinical Pathology/Laboratory Medicine providers received nationally (typical 2025 total: $114).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,814 · 2021: $2,040 · 2023: $48.19 · 2024: $128 · 2025: $4,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $1,083 · Travel and Lodging: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $1,083.13 |
| Travel and Lodging | $1,043.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofire Diagnostics, LLC | $3,795.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $2,500.00 | 2025 | |
| Roche Diagnostics Corporation | $1,950.00 | 2021 | |
| Biomerieux INC | $1,447.70 | 2025 | Vitek2 |
| Werfen USA LLC | $391.41 | 2025 | |
| Cepheid | $139.50 | 2021-2025 | Genexpert |
| Abbott Laboratories | $128.38 | 2024 | Alinity |
| Boston Scientific Corporation | $77.47 | 2023-2025 | Watchman Access System, Varithena Administration Pack |
| Quidel Corporation | $32.14 | 2023 | |
| Beckman Coulter, INC. | $18.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Benavides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.